| 000 | 01817 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514162631.0 | ||
| 264 | 0 | _c20040226 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a1073-449X | ||
| 024 | 7 |
_a10.1164/rccm.200307-957OC _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarst, Robyn J | |
| 245 | 0 | 0 |
_aSitaxsentan therapy for pulmonary arterial hypertension. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cFeb 2004 |
||
| 300 |
_a441-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnaerobic Threshold |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 | _aExercise Test |
| 650 | 0 | 4 | _aExercise Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aIsoxazoles _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOxygen Consumption |
| 650 | 0 | 4 |
_aThiophenes _xadverse effects |
| 700 | 1 | _aLangleben, David | |
| 700 | 1 | _aFrost, Adaani | |
| 700 | 1 | _aHorn, Evelyn M | |
| 700 | 1 | _aOudiz, Ronald | |
| 700 | 1 | _aShapiro, Shelley | |
| 700 | 1 | _aMcLaughlin, Vallerie | |
| 700 | 1 | _aHill, Nicholas | |
| 700 | 1 | _aTapson, Victor F | |
| 700 | 1 | _aRobbins, Ivan M | |
| 700 | 1 | _aZwicke, Diane | |
| 700 | 1 | _aDuncan, Benjamin | |
| 700 | 1 | _aDixon, Richard A F | |
| 700 | 1 | _aFrumkin, Lyn R | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 169 _gno. 4 _gp. 441-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/rccm.200307-957OC _zAvailable from publisher's website |
| 999 |
_c14366987 _d14366987 |
||